Fibroblast growth factors 19 and 21 in acute liver damage

Currently there are very few pharmacological options available to treat acute liver injury. Because its natural exposure to noxious stimuli the liver has developed a strong endogenous hepatoprotective capacity. Indeed, experimental evidence exposed a variety of endogenous hepatic and systemic respon...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Transl Med
Egile Nagusiak: Shan, Zhao, Alvarez-Sola, Gloria, Uriarte, Iker, Arechederra, María, Fernández-Barrena, Maite G., Berasain, Carmen, Ju, Cynthia, Avila, Matías A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2018
Gaiak:
Review Article on Molecular Hepatology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6046301/
https://ncbi.nlm.nih.gov/pubmed/30069459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.05.26
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak